سیویلیکا را در شبکه های اجتماعی دنبال نمایید.

Interactions of smoking with rs833061 polymorphism on the risk of non-alcoholic fat liver disease in Hubei Han population: a preliminary case–control study

Publish Year: 1394
Type: Journal paper
Language: English
View: 178

This Paper With 6 Page And PDF Format Ready To Download

Export:

Link to this Paper:

Document National Code:

JR_IJBMS-18-11_009

Index date: 25 October 2021

Interactions of smoking with rs833061 polymorphism on the risk of non-alcoholic fat liver disease in Hubei Han population: a preliminary case–control study abstract

Objective(s):Vascular endothelial growth factor (VEGF) has biological actions on energy homeostasis, inflammation and insulin resistance. The present study aimed to investigate the association between VEGF -460 T/C (rs833061), and +936 C/T (rs3025039) polymorphism and risk of non-alcohol fatty liver disease (NAFLD) in Hubei Han population and to further explore the interactions of smoking with rs833061 and rs3025039. Materials and Methods:341 healthy controls and 246 cases were recruited. Two variants, rs833061 and rs3025039, were genotyped by polymerase chain reaction (PCR)-restriction fragment length polymorphism (RFLP). The unconditional logistic regression (ULR) was performed to assess the association of the two variants with risk of NAFLD. Gene-environment interactions on the risk of NAFLD were preliminarily explored by generalized multifactor dimensionality reduction (GMDR) and further confirmed by ULR methods. Results:After adjusting for covariates, increased risk of NAFLD was observed in patients carrying CT/CC genotypes in rs833061 and rs3025039 (ORa=1.80, 95% confidence interval (CI): 1.51, 2.36, Pa=0.000; ORa=1.89, 95% CI: 1.41, 2.82, Pa=0.000, respectively). Interaction of smoking with rs833061 was found by GMDR, with maximum prediction accuracy (67.91%) and a maximum cross-validation consistency (10/10). ULR method confirmed that, smoking-positive patients with genotype CT/CC had 4.93 times risk of NAFLD compared to smoking-negative participants with genotype TT (ORadda=4.93, 95% CI:2.91, 8.54, Padda=0.000), which further confirmed synergistic effects. Conclusion: The results indicated that both rs833061 and rs3025039 are associated with NAFLD risk. Furthermore, rs833061 is likely to have an interaction with smoking, and they have synergistic effects on risk of NAFLD in Hubei Han population.

Interactions of smoking with rs833061 polymorphism on the risk of non-alcoholic fat liver disease in Hubei Han population: a preliminary case–control study Keywords:

Interactions of smoking with rs833061 polymorphism on the risk of non-alcoholic fat liver disease in Hubei Han population: a preliminary case–control study authors

Pengbo Wu

Department of Gastroenterology, Renmin Hospital of Wuhan University, Jiefang Road, Wuhan, China

Yonglong Hua

Department of Gastroenterology, Renmin Hospital of Tongcheng, Minzhu Road ۱۲۰, Hubei, China

Shiyun Tan

Department of Gastroenterology, Renmin Hospital of Wuhan University, Jiefang Road, Wuhan, China

Ming Li

Department of Gastroenterology, Renmin Hospital of Wuhan University, Jiefang Road, Wuhan, China

Shu Yongxiang

Department of Gastroenterology, Renmin Hospital of Wuhan University, Jiefang Road, Wuhan, China

Guo Fang

Department of Gastroenterology, Renmin Hospital of Wuhan University, Jiefang Road, Wuhan, China

مراجع و منابع این Paper:

لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :
Mendez-Sanchez N, Arrese M, Zamora-Valdes D, Uribe M. Current concepts ...
Zhou YJ, Li YY, Nie YQ, Ma JX, Lu LG, ...
Macut D, Bjekic-Macut J, Savic-Radojevic A. Dys-lipidemia and oxidative stress ...
San Millan JL, Corton M, Villuendas G, Sancho J, Peral ...
Zhang C, Guo L, Guo X. [Interaction of polymer-phisms of ...
Oniki K, Hori M, Saruwatari J, Morita K, Kajiwara A, ...
Elias I, Franckhauser S, Bosch F. New insights into adipose ...
۹.Sun K, Wernstedt Asterholm I, Kusminski CM, Bueno AC, Wang ...
Murray CJ, Roth G. Progress and challenges in the fight ...
۱۱.Liu Y, Dai M, Bi Y, Xu M, Xu Y, ...
Fatty Liver and Alcoholic Liver Disease Study Group of Chinese ...
Lou XY, Chen GB, Yan L, Ma JZ, Zhu J, ...
Andersson T, Alfredsson L, Kallberg H, Zdravkovic S, Ahlbom A. ...
Belo VA, Souza-Costa DC, Luizon MR, Izidoro-Toledo TC, Lanna CM, ...
Moradzadegan A, Vaisi-Raygani A, Nikzamir A, Rahimi Z. Angiotensin converting ...
Guruvaiah P, Govatati S, Reddy TV, Lomada D, Deenadayal M, ...
Sivaprasad S, Govardhan B, Harithakrishna R, Venkat Rao G, Pradeep ...
Kim HW, Ko GJ, Kang YS, Lee MH, Song HK, ...
Chiolero A, Faeh D, Paccaud F, Cornuz J. Consequences of ...
Zhang LW, Li JP, Duan FF, Liu ZK, Zhan SY, ...
Fesinmeyer MD, North KE, Lim U, Buzkova P, Crawford DC, ...
Wieckowska A, Feldstein AE. Diagnosis of nonalcoholic fatty liver disease: ...
نمایش کامل مراجع